Exact Mass: 460.3188574
Exact Mass Matches: 460.3188574
Found 500 metabolites which its exact mass value is equals to given mass value 460.3188574,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
ST 27:4;O6
Same as: D09796
Lucidenic acid N
Lucidenic acid N is found in mushrooms. Lucidenic acid N is a constituent of Ganoderma lucidum (reishi).
(3beta,5alpha,6beta,9alpha,22E,24R)-23-Methylergosta-7,22-diene-3,5,6,9-tetrol
(3beta,5alpha,6beta,9alpha,22E,24R)-23-Methylergosta-7,22-diene-3,5,6,9-tetrol is found in mushrooms. (3beta,5alpha,6beta,9alpha,22E,24R)-23-Methylergosta-7,22-diene-3,5,6,9-tetrol is a constituent of Lentinula edodes (shiitake). Constituent of Lentinula edodes (shiitake). (3beta,5alpha,6beta,9alpha,22E,24R)-23-Methylergosta-7,22-diene-3,5,6,9-tetrol is found in mushrooms.
Polyporusterone D
Polyporusterone D is found in mushrooms. Polyporusterone D is a constituent of Polyporus umbellatus (zhu ling). Constituent of Polyporus umbellatus (zhu ling). Polyporusterone D is found in mushrooms.
2,3-Secoporrigenin
(6beta,25S)-2,3-Secospirostan-3,6-olid-2-oic acid is found in onion-family vegetables. (6beta,25S)-2,3-Secospirostan-3,6-olid-2-oic acid is a constituent of Allium porrum (leek)
Polyporusterone E
Polyporusterone E is found in mushrooms. Polyporusterone E is a constituent of Polyporus umbellatus (zhu ling). Constituent of Polyporus umbellatus (zhu ling). Polyporusterone E is found in mushrooms.
(3beta,5alpha,9alpha,14alpha,22E,24R)-3,5,9,14-Tetrahydroxyergosta-7,22-dien-6-one
(3beta,5alpha,9alpha,14beta,22E,24R)-3,5,9,14-Tetrahydroxyergosta-7,22-dien-6-one is found in mushrooms. (3beta,5alpha,9alpha,14beta,22E,24R)-3,5,9,14-Tetrahydroxyergosta-7,22-dien-6-one is a constituent of Tricholoma matsutake (matsutake).
Polyporusterone G
Polyporusterone G is found in mushrooms. Polyporusterone G is a constituent of Polyporus umbellatus (zhu ling). Constituent of Polyporus umbellatus (zhu ling). Polyporusterone G is found in mushrooms.
13'-Carboxy-alpha-tocopherol
13-carboxy-alpha-tocopherol is a dehydrogenation carboxylate product of 13-hydroxy-a-tocopherol by an unidentified microsomal enzyme(s) probably via an aldehyde intermediate. The tocopherols ( a-tocopherol , b-tocopherol ,r-tocopherol and d-tocopherol ) and their corresponding tocotrienols are synthesized by plants and have vitamin E antixoidant activity (see pathway vitamin E biosynthesis ). They differ in the number and location of methyl groups on the chromanol ring. The naturally occurring form of a-tocopherol is (2R,4R,8R)-a-tocopherol (synonym (R,R,R)-a-tocopherol). Synthetic a-tocopherols are a racemic mixture of eight different R and S stereoisomers. Only the 2R forms are recognized as meeting human requirements. The in vivo function of vitamin E is to scavenge peroxyl radicals via its phenolic (chromanol) hydroxyl group, thus protecting lipids against free radical-catalyzed peroxidation. The tocopheryl radical formed can then be reduced by reductants such as L-ascorbate. Other major products of a-tocopherol oxidation include α-tocopherylquinone and epoxy-a-tocopherols. The metabolites a-tocopheronic acid and its lactone, known as the Simon metabolites, are generally believed to be artefacts. In addition to these oxidation products, the other major class of tocopherol metabolites is the carboxyethyl-hydroxychromans.These metabolites are produced in significant amounts in response to excess vitamin E ingestion. Vitamin E is fat-soluble and its utilization requires intestinal fat absorption mechanisms. It is secreted from the intestine into the lymphatic system in chylomicrons which subsequently enter the plasma. Lipolysis of these chylomicrons can result in delivery of vitamin E to tissues, transfer to high-density lipoproteins (and subsequently to other lipoproteins via the phospholipid exchange protein), or retention in chylomicron remnants. These remnants are taken up by the liver. Natural (R,R,R)-α-tocopherol and synthetic 2R-α-tocopherols are then preferentially secreted from the liver into plasma as a result of the specificity of the α-tocopherol transfer protein. This protein, along with the metabolism of excess vitamin E in the liver and excretion into urine and bile, mediate the supply of a-tocopherol in plasma and tissues. 13-carboxy-alpha-tocopherol is a dehydrogenation carboxylate product of 13-hydroxy-a-tocopherol by an unidentified microsomal enzyme(s) probably via an aldehyde intermediate
all-trans-Carophyll yellow
Colour additive for foods, e.g. egg yolks. Colour additive for foods, e.g. egg yolks
N-Arachidonoyl Arginine
C26H44N4O3 (460.34132339999996)
N-arachidonoyl arginine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Arachidonic acid amide of Arginine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Arachidonoyl Arginine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Arachidonoyl Arginine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Food orange 7
Lexacalcitol
Menatetrenone Epoxide
Petrosaspongiolide m
DG(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)
DG(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/2:0/0:0)
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))
DG(2:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/2:0)
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)
DG(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0/0:0)
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))
DG(2:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/2:0)
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)
DG(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0/0:0)
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))
DG(2:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/2:0)
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)
DG(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0/0:0)
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))
DG(2:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/2:0)
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)
DG(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0/0:0)
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))
DG(2:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/2:0)
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
2-Deoxy-25-Methyldolichosterone
2-deoxy-25-methyldolichosterone belongs to trihydroxy bile acids, alcohols and derivatives class of compounds. Those are prenol lipids structurally characterized by a bile acid or alcohol which bears three hydroxyl groups. 2-deoxy-25-methyldolichosterone is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 2-deoxy-25-methyldolichosterone can be found in common bean, green bean, and yellow wax bean, which makes 2-deoxy-25-methyldolichosterone a potential biomarker for the consumption of these food products.
3-epi-2-Deoxy-25-methyldolichosterone
3-epi-2-deoxy-25-methyldolichosterone belongs to trihydroxy bile acids, alcohols and derivatives class of compounds. Those are prenol lipids structurally characterized by a bile acid or alcohol which bears three hydroxyl groups. 3-epi-2-deoxy-25-methyldolichosterone is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 3-epi-2-deoxy-25-methyldolichosterone can be found in common bean, green bean, and yellow wax bean, which makes 3-epi-2-deoxy-25-methyldolichosterone a potential biomarker for the consumption of these food products.
Lucidenic acid N
Lucidenic acid N is a tetracyclic triterpenoid that is 25,26,27-trinorlanost-8-en-24-oic acid substituted by hydroxy groups at positions 3 and 7 and oxo groups at positions 11 and 15 respectively (the 3beta,5alpha,7beta stereoisomer). Isolated from the fruiting bodies of Ganoderma lucidum, it exhibits cytotoxicity against tumour cells. It has a role as a metabolite, an EC 3.1.1.8 (cholinesterase) inhibitor and an antineoplastic agent. It is a tetracyclic triterpenoid, a cyclic terpene ketone, a dioxo monocarboxylic acid and a secondary alcohol. Lucidenic acid N is a natural product found in Ganoderma lucidum and Bos taurus with data available. A tetracyclic triterpenoid that is 25,26,27-trinorlanost-8-en-24-oic acid substituted by hydroxy groups at positions 3 and 7 and oxo groups at positions 11 and 15 respectively (the 3beta,5alpha,7beta stereoisomer). Isolated from the fruiting bodies of Ganoderma lucidum, it exhibits cytotoxicity against tumour cells. Constituent of Ganoderma lucidum (reishi). Lucidenic acid N is found in mushrooms.
12beta,20-Dihydroxy-16beta-Acetoxy-17-scalaren-19,20-olide
1-O-17-Methylstearylmyoinosit|1-O-17-Methylstearylmyrinosit
(25S)-3beta,4beta,6alpha,26-tetrahydroxy-24-methyl-5alpha-cholesta-8(14),24(241)-dien-15-one|certonardosterol Q5
2-Propyl-8-hydroxymethyl-12,14-dimethyl-15-benzyl-1-oxa-7,14-diazacyclohexadecane-6,13,16-trione
C26H40N2O5 (460.29370700000004)
cholest-5-ene-1alpha,3beta,11alpha-triol 11-acetate
12-Ac 鈥樎?2alpha-24,25-Epoxy-20,24-dimethyl-12,24-scalaranediol
5alpha,6alpha-epoxy-3beta,8beta,14alpha-trihydroxy-5alpha-ergosta-22E-en-7-one
(22E)-11-acetoxy-3beta,6alpha-dihydroxy-24-nor-9,11-seco-5alpha-cholesta-7,22-dien-9-one
2-O-[(3R,7R)-3-(acetyloxy)-7-hydroxyeicosanoyl]glycerol
namogenin C|spirosta-5,25(27)-dien-1beta,3beta,14alpha,17alpha-tetrol
3alpha-(4-pent-2E-enoyloxy-pent-2E-enoyloxy)-9alpha-hydroxy-7beta,10alphaH-eremophil-11-ene-8-one|3alpha-<4-pent-2E-enoyloxy-pent-2E-enoyloxy>-9alpha-hydroxy-7beta,10alphaH-eremophil-11-ene-8-one
2-O-[(3R,9R)-3-(acetyloxy)-9-hydroxyeicosanoyl]glycerol
polyporusterone G
17,24-epoxy-20alpha,25-dihydroxy-21-norbaccharan-3-one
A natural product found in Aglaia foveolata.
(alpha5R,2R,5S,3E,7E)-alpha5-<9-(5-hydroxy-2-methoxy-3-methylphenyl)-3,7-dimethylnona-3,7-dienyl>-alpha2,alpha2,5-trimethyltetrahydrofuran-2,5-dimethanol
3alpha,9beta,13alpha-trihydroxy-11(12),15(17)-trinervitadiene propionate diacetate
spirosta-5,25(27)-diene-1beta,2alpha,3beta,12beta-tetrol
(3beta,17(21)E,22R,23R,24R)-23-Methylrgosta-5,17-diene-3,22,23,25-tetrol
(22E)-3,5,6,7-tetrahydroxyergosta-8,22-dien-15-one|penicillisterol
(17R)-19(18?17)-abeo-3alpha,18beta,23,24-tetrahydroxy-28-norolean-12-ene|stewertiisin A
1alpha,3beta,4beta-trihydroxy-24,30-dinorolean-6-ene-28-oic acid
cholesta-5-en-3beta,7beta,19-triol 19-acetate|nebrosteroid N
2-O-[(3R,8R)-3-(acetyloxy)-8-hydroxyeicosanoyl]glycerol
2-O-[(3R,6S)-3-(acetyloxy)-6-hydroxyeicosanoyl]glycerol
6-Angeloyl,7-Ac-6,7-Dihydroxy-3,13-clerodadien-15-oic acid
7beta-hydroxy-11-oxo-3,4-seco-25,26,27-trinorlanosta-4(28),8-dien-3,24-dioic acid|fornicatin B
(12alpha,25xi)-24,25-Epoxy-24-methyl-16-scalarene-12,22,25-triol
3alpha-(4-pent-2E-enoyloxy-pent-2E-enoyloxy)-9alpha-hydroxy-10alphaH-eremophil-7(11)-ene-8-one|3alpha-<4-pent-2E-enoyloxy-pent-2E-enoyloxy>-9alpha-hydroxy-10alphaH-eremophil-7(11)-ene-8-one
(1S,3R,5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraene-1,3,24,25,28-pentol
24-methylene-1alpha,3beta,11alpha-trihydroxycholest-5-en-18-oic acid|24-methylene-1alpha,3beta,11alpha-trihydroxycholest-5en-18-oic acid
12alpha-acetoxy-16beta-hydroxy-24-methyl-24-oxoscalaran-25-al
Eicosapentaenoyl Serotonin
3β,7β,15β-Trihydroxy-11-oxo-lanosta-8-en-24→20 lactone
7,15-Dihydroxy-4,4,14-trimethyl-3,11-dioxochol-8-en-24-oic acid
Lys Lys Ser Val
Lys Lys Val Ser
Lys Ser Lys Val
Lys Ser Val Lys
Lys Val Lys Ser
Lys Val Ser Lys
Ser Lys Lys Val
Ser Lys Val Lys
Ser Val Lys Lys
Val Lys Lys Ser
Val Lys Ser Lys
Val Ser Lys Lys
(6R)-vitamin D2 6,19-sulfur dioxide adduct / (6R)-ergocalciferol 6,19-sulfur dioxide adduct
(6S)-vitamin D2 6,19-sulfur dioxide adduct / (6S)-ergocalciferol 6,19-sulfur dioxide adduct
(24R)-1α,24,25,26-tetrahydroxyvitamin D2 / (24R)-1α,24,25,26-tetrahydroxyergocalciferol
1α,24,25,28-tetrahydroxyvitamin D2 / 1α,24,25,28-tetrahydroxyergocalciferol
1α-hydroxy-2β-(2-hydroxyethoxy)vitamin D3 / 1α-hydroxy-2β-(2-hydroxyethoxy)cholecalciferol
(5Z,7E)-(1S,3R,20S)-20-methoxy-24a-homo-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
(5Z,7E)-(1S,3R)-24a,24b,24c-trihomo-22-oxa-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
(5Z,7E)-(1S,3R)-26,27-dimethyl-24a-homo-22-oxa-9,10-seco-5,7,10(19)-cholestatrien-1,3,25-triol
(5Z,7E)-(1S,3R)-20,26,27-trimethyl-23-oxa-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
(5Z,7E)-(1S,3R,20R)-26,27-dimethyl-24a-homo-22-oxa-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
(5Z,7E)-(1S,3R,11S)-11-(2-hydroxyethyl)-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
(5Z,7E)-(1S,3R,11R)-11-(2-hydroxyethyl)-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
(5Z,7E)-(1S,3R,20R,22R)-24a,24b-dihomo-9,10-seco-5,7,10(19)-cholestatriene-1,3,22,25-tetrol
(5Z,7E)-(1S,3R,20S)-24a,24b-dihomo-9,10-seco-5,7,10(19)-cholestatriene-1,3,20,25-tetrol
(5Z,7E)-(1S,3R,20S)-26,27-dimethyl-9,10-seco-5,7,10(19)-cholestatriene-1,3,20,25-tetrol
(5Z,7E)-(1S,3R,20R,22R)-26,27-dimethyl-9,10-seco-5,7,10(19)-cholestatriene-1,3,22,25-tetrol
(5Z,7E)-(1S,3R,22S)-26,27-dimethyl-9,10-seco-5,7,10(19)-cholestatriene-1,3,22,25-tetrol
(5Z,7E)-(1S,3R,20S)-26,27-dimethyl-24a-homo-9,10-seco-5,7,10(19)-cholestatriene-1,3,20,25-tetrol
(5Z,7E)-(1S,3R)-18-(5-hydroxy-5-methylhexyloxy)-23,24-dinor-9,10-seco-5,7,10(19)-cholatriene-1,3-diol
24-Nor-9,11-seco-11-acetoxy-3,6-dihydroxycholest-7,22-dien-9-one
2,3-Secoporrigenin
(3beta,5alpha,9alpha,14alpha,22E,24R)-3,5,9,14-Tetrahydroxyergosta-7,22-dien-6-one
FOOD Orange 7
(3beta,5alpha,6beta,9alpha,22E,24R)-23-Methylergosta-7,22-diene-3,5,6,9-tetrol
Polyporusterone E
Polyporusterone D
bhas#34
An (omega-1)-hydroxy fatty acid ascaroside that is ascr#34 in which the pro-R hydrogen that is beta to the carboxy group is replaced by a hydroxy group. It is a metabolite of the nematode Caenorhabditis elegans.
bhos#34
An omega-hydroxy fatty acid ascaroside that is oscr#34 in which the pro-R hydrogen beta to the carboxy group is replaced by a hydroxy group. It is a metabolite of the nematode Caenorhabditis elegans.
Strophasterol E
Strophasterol F
(6R)-vitamin D2 6,19-sulfur dioxide adduct
(6S)-vitamin D2 6,19-sulfur dioxide adduct
(24R)-1alpha,24,25,26-tetrahydroxyvitamin D2
1alpha,24,25,28-tetrahydroxyvitamin D2
1alpha-hydroxy-2beta-(2-hydroxyethoxy)vitamin D3
(20S)-1alpha,25-dihydroxy-20-methoxy-24a-homovitamin D3
1alpha,25-dihydroxy-24a,24b,24c-trihomo-22-oxavitamin D3
1alpha,25-dihydroxy-26,27-dimethyl-24a-homo-22-oxavitamin D3 / 1alpha,25-dihydroxy-26,27-dimethyl-24a-homo-22-oxacholecalciferol
1alpha,25-dihydroxy-20,26,27-trimethyl-23-oxavitamin D3 / 1alpha,25-dihydroxy-20,26,27-trimethyl-23-oxacholecalciferol
1alpha,25-dihydroxy-26,27-dimethyl-24a-homo-22-oxa-20-epivitamin D3
1alpha,25-dihydroxy-11alpha-(2-hydroxyethyl)vitamin D3
1alpha,25-dihydroxy-11beta-(2-hydroxyethyl)vitamin D3
(22R)-1alpha,22,25-trihydroxy-24a,24b-dihomo-20-epivitamin D3
(20S)-1alpha,20,25-trihydroxy-24a,24b-dihomovitamin D3
(20S)-14alpha,20,25-trihydroxy-26,27-dimethylvitamin D3
(20S)-1alpha,20,25-trihydroxy-26,27-dimethyl-24a-homovitamin D3
13-carboxychromanol
Omega-hydroxymenaquinone-4
A prenylnaphthoquinone obtained by hydroxylation of one of the terminal methyl groups of menaquinone-4.
Lexacalcitol
D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D000970 - Antineoplastic Agents
6b-Hydroxymethandienone
C26H44O3Si2 (460.28288339999995)
6b-Hydroxymethandienone is a metabolite of the androgen metandienone metabolite, excreted in the urine. Metandienone has been used in horse doping and by weightlifters and body builders. It is of note to consider that the use of anabolic steroids for an extended period of time reduces the excretion of endogenous metabolites, making the detection of doping a little more difficult. (PMID: 16040239, 757586, 9001954, 2745643, 12375280, 8539789, 1400752, 757586, 17610244) [HMDB]
POLY(DIMETHYLSILOXANE), DISTEARATE TERMINATED
C26H52O2S2 (460.34085319999997)
1,1-[Oxybis(methylene-4,1-phenyleneoxy)]bis[3-(isopropylamino)-2-propanol]
C26H40N2O5 (460.29370700000004)
(3R)-19-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]-3-hydroxynonadecanoic acid
(3R,18R)-18-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]-3-hydroxynonadecanoic acid
Ergosta-7,20-dien-6-one, 2,3,14,22-tetrahydroxy-, (2beta,3beta,5beta,22R)-
Ergost-7-en-6-one, 22,23-epoxy-2,3,14-trihydroxy-, (2beta,3beta,5beta,22S,23S)-
(2beta,3beta,5beta,22R)-2,3,14,22-Tetrahydroxyergosta-7,24(28)-dien-6-one
(24R)-1alpha,24,25,26-tetrahydroxyvitamin D2/(24R)-1alpha,24,25,26-tetrahydroxyergocalciferol
1alpha,24,25,28-tetrahydroxyvitamin D2/1alpha,24,25,28-tetrahydroxyergocalciferol
(5Z)-5-[(2E)-2-[1-[1-(4-ethyl-4-hydroxyhexoxy)ethyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
[3-carboxy-2-[(E)-7-[(5Z)-5-[(E)-oct-2-enylidene]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxypropyl]-trimethylazanium
C27H42NO5+ (460.30628220000006)
(1R,2R,5S,8S,10R,11S,14R,15R,20R)-5-hydroxy-8-(2-hydroxypropan-2-yl)-1,2,15,19,19-pentamethyl-9-oxapentacyclo[12.8.0.02,11.05,10.015,20]docosan-18-one
3-cyclohexyl-1-[[(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2S,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2S,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2R,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
1-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-cyclohexyl-3-[(4R,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H40N4O4 (460.30494000000004)
1-cyclohexyl-3-[(4S,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H40N4O4 (460.30494000000004)
1-cyclohexyl-3-[(4R,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H40N4O4 (460.30494000000004)
1-[(4S,7S,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(4R,7R,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(4S,7R,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(4R,7S,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2R,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2R,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2R,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2R,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2S,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2R,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2R,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
1-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-cyclohexyl-3-[(4S,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H40N4O4 (460.30494000000004)
1-cyclohexyl-3-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H40N4O4 (460.30494000000004)
1-cyclohexyl-3-[(4R,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H40N4O4 (460.30494000000004)
1-cyclohexyl-3-[(4R,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H40N4O4 (460.30494000000004)
1-cyclohexyl-3-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H40N4O4 (460.30494000000004)
1-[(4S,7S,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(4S,7R,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(4R,7R,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(4R,7S,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
(1-hydroxy-3-octoxypropan-2-yl) (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
[1-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propan-2-yl] octanoate
[1-hydroxy-3-[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoxy]propan-2-yl] acetate
[1-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]propan-2-yl] hexanoate
[1-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoxy]-3-hydroxypropan-2-yl] butanoate
[3-carboxy-2-[(9E,11E,13E,15E,17E)-henicosa-9,11,13,15,17-pentaenoyl]oxypropyl]-trimethylazanium
C28H46NO4+ (460.34266560000003)
(1-hydroxy-3-propanoyloxypropan-2-yl) (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate
(1-hydroxy-3-pentanoyloxypropan-2-yl) (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
(1-heptanoyloxy-3-hydroxypropan-2-yl) (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
[3-(3-Acetyloxy-2-dodecanoyloxypropoxy)-1-carboxypropyl]-trimethylazanium
[1-Carboxy-3-(3-propanoyloxy-2-undecanoyloxypropoxy)propyl]-trimethylazanium
[1-Carboxy-3-(3-hexanoyloxy-2-octanoyloxypropoxy)propyl]-trimethylazanium
[1-Carboxy-3-(2-nonanoyloxy-3-pentanoyloxypropoxy)propyl]-trimethylazanium
[1-Carboxy-3-[2,3-di(heptanoyloxy)propoxy]propyl]-trimethylazanium
[3-(3-Butanoyloxy-2-decanoyloxypropoxy)-1-carboxypropyl]-trimethylazanium
2-[carboxy-[2-hydroxy-3-[(Z)-tetradec-9-enoyl]oxypropoxy]methoxy]ethyl-trimethylazanium
3beta,6alpha-dihydroxy-11-acetoxy-24-nor-9,11-seco-cholest-7,22E-diene-9-one
(7E)-(3S,6R)-6,19-epithio-9,10-seco-5(10),7,22-ergostatrien-3-ol S,S-dioxide
2,3-epoxymenatetrenone
A member of the class of tetralins obtained by formal epoxidation across the 2,3-double bond of menatetrenone.
TG(24:5)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
DG(26:5)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
5,8,11,15-tetramethyl-4-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadec-14-en-12-yl octanoate
2-[(1s,2r,5r)-2-[(4s,4as,6s,8as)-4,6-dihydroxy-8a-methyl-1-oxo-4,4a,5,6,7,8-hexahydronaphthalen-2-yl]-1-methyl-5-[(2r,3e)-5-methylhex-3-en-2-yl]cyclopentyl]ethyl acetate
2-[(1r,2r,5r)-2-[(4s,4as,6s,8as)-4,6-dihydroxy-8a-methyl-1-oxo-4,4a,5,6,7,8-hexahydronaphthalen-2-yl]-1-methyl-5-[(2r,3e)-5-methylhex-3-en-2-yl]cyclopentyl]ethyl acetate
(1r,2r,4r,5s,8r,13s,14s,17s,18r,20r)-5,9,9,13-tetramethyl-22-oxo-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-2-yl acetate
1,3-dihydroxypropan-2-yl 3-(acetyloxy)-9-hydroxyicosanoate
(3s,4ar,6ar,8s,10r,10ar,10bs)-8-(acetyloxy)-3-ethenyl-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-10-yl (2z)-2-methylbut-2-enoate
(1r,3r,5as,5br,7as,11ar,11br,13s,13as,13bs)-1-hydroxy-11a-(hydroxymethyl)-3,5b,8,8,13a-pentamethyl-1h,3h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h,13bh-chryseno[1,2-c]furan-13-yl acetate
(1r,5s,5as,6r,7s,9ar,9br,11ar)-5,6,7-trihydroxy-1-[(2r,6s)-7-hydroxy-6-methyl-5-methylideneheptan-2-yl]-9a,11a-dimethyl-1h,2h,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-3-one
2-[2-(4-methoxy-4-methylpent-2-en-1-yl)-5-(methoxymethyl)-2-methyl-6-oxo-7-(2-oxopropyl)cyclohept-4-en-1-yl]ethenyl 3-methylbut-2-enoate
(1e)-2-[(4r,5s,7s,8s)-8-(hydroxymethyl)-7,8-dimethoxy-2,5-dimethyl-5-(4-methylpent-3-en-1-yl)-4h,6h,7h-cyclohepta[b]furan-4-yl]ethenyl 3-methylbut-2-enoate
(1'r,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,16'r,18's,19'r)-16',19'-dihydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-10',15'-dione
4-hydroxy-2-methyl-5-[(14z)-nonadec-14-en-1-yl]-3,6-dioxocyclohexa-1,4-dien-1-yl acetate
8-[6-(acetyloxy)-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-6-methyl-2-(4-methylpentyl)octanoic acid
1,3-dihydroxypropan-2-yl (3r,8r)-3-(acetyloxy)-8-hydroxyicosanoate
(2s,3as,5s)-3a-(3,7-dimethylocta-2,6-dien-1-yl)-5-hydroxy-2-(2-hydroxypropan-2-yl)-5-methyl-7-[(2r)-2-methylbutanoyl]-2,3-dihydro-1-benzofuran-4,6-dione
3β,5α,9α,14β-tetrahydroxy-(22e)-ergosta-7,22-dien-6-one
{"Ingredient_id": "HBIN008091","Ingredient_name": "3\u03b2,5\u03b1,9\u03b1,14\u03b2-tetrahydroxy-(22e)-ergosta-7,22-dien-6-one","Alias": "NA","Ingredient_formula": "C28H44O5","Ingredient_Smile": "CC(C)C(C)C=CC(C)C1CCC2(C1(CCC3(C2=CC(=O)C4(C3(CCC(C4)O)C)O)O)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21090","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5,9,9,13-tetramethyl-22-oxo-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-2-yl acetate
(1r,3as,5ar,7r,8s,9ar,9br,11ar)-3a,7,8-trihydroxy-9a,11a-dimethyl-1-[(1s)-1-[(2s,3s)-3-[(2r)-3-methylbutan-2-yl]oxiran-2-yl]ethyl]-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
3-(2-hydroxy-5-oxo-2h-furan-3-yl)-4b,7,7,10a-tetramethyl-tetradecahydrophenanthro[2,1-c]pyran-1-yl acetate
(1z)-2-[(1s,3s,5s,11s,12r)-3-methoxy-11-[(2e)-4-methoxy-4-methylpent-2-en-1-yl]-3,11-dimethyl-2,6-dioxatricyclo[6.4.0.0¹,⁵]dodec-8-en-12-yl]ethenyl 3-methylbut-2-enoate
2-[2-(4,6-dihydroxy-8a-methyl-1-oxo-4,4a,5,6,7,8-hexahydronaphthalen-2-yl)-1-methyl-5-(5-methylhex-3-en-2-yl)cyclopentyl]ethyl acetate
(1r,3as,4r,5s,5as,7s,9ar,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-4,5,5a,7-tetrahydroxy-9a,11a-dimethyl-1h,2h,3ah,4h,5h,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-3-one
16',19'-dihydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-10',15'-dione
(1's,2s,2's,4s,4's,7'r,8'r,9's,12's,13's,16'r,18's)-7',16'-dihydroxy-4,5,5,7',9',13'-hexamethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-11'-one
4-[6-(2-carboxyethyl)-9-hydroxy-3a,6,9b-trimethyl-5-oxo-7-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h,9h-cyclopenta[a]naphthalen-3-yl]pentanoic acid
2-[3-methoxy-11-(4-methoxy-4-methylpent-2-en-1-yl)-3,11-dimethyl-2,6-dioxatricyclo[6.4.0.0¹,⁵]dodec-8-en-12-yl]ethenyl 3-methylbut-2-enoate
(1r,3as,3bs,4r,9ar,9bs,11ar)-4-hydroxy-9a,11a-dimethyl-1-[(2s,3r,5r)-3,5,6-trihydroxy-5,6-dimethylheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
(3s,4as,6s)-4a-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-3,6-dihydroxy-2,2,6-trimethyl-8-[(2r)-2-methylbutanoyl]-3,4-dihydro-1-benzopyran-5,7-dione
(4r)-4-[(1r,3ar,4s,5as,7s,9as,11ar)-4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]pentanoic acid
3a,7-dihydroxy-1-[6-hydroxy-5-(hydroxymethyl)-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
(1e)-2-[(1s,3r,5s,11s,12r)-3-methoxy-11-[(2e)-4-methoxy-4-methylpent-2-en-1-yl]-3,11-dimethyl-2,6-dioxatricyclo[6.4.0.0¹,⁵]dodec-8-en-12-yl]ethenyl 3-methylbut-2-enoate
(1's,3r,3ar,7's,9's,15as)-1',6,7',10,14-pentamethyl-3a,4,5,8,9,12,13,15a-octahydrospiro[cyclotetradeca[b]furan-3,10'-tricyclo[7.2.1.0²,⁸]dodecane]-2'(8'),3'-dien-2-one
12-{4-[2-(dimethylamino)ethyl]phenoxymethyl}-5-methyl-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadeca-6,12-dien-9-ol
(2s,3ar)-4-hydroxy-7-{[(1r,2s,5r)-2-hydroxy-2-methyl-5-(prop-1-en-2-yl)cyclopentyl]methyl}-2-(2-hydroxypropan-2-yl)-3a-methyl-5-[(2r)-2-methylbutanoyl]-2,3-dihydro-1-benzofuran-6-one
8-(acetyloxy)-3-ethenyl-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-10-yl 3-methylbut-2-enoate
3a,7,8-trihydroxy-1-(3-hydroxy-6-methyl-5-methylideneheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
(2r,3as)-4-hydroxy-7-{[(1s,2r,5s)-2-hydroxy-2-methyl-5-(prop-1-en-2-yl)cyclopentyl]methyl}-2-(2-hydroxypropan-2-yl)-3a-methyl-5-[(2s)-2-methylbutanoyl]-2,3-dihydro-1-benzofuran-6-one
[2-(2-hydroxy-5-oxo-2h-furan-3-yl)-3b,6,6,9a-tetramethyl-dodecahydrophenanthro[2,1-b]furan-11a-yl]methyl acetate
3',4,7'-trihydroxy-3',5,7'-trimethyl-5-(3-methylbut-2-en-1-yl)-3-(2-methylbutanoyl)-1',2',3'a,4',6',7'a-hexahydrospiro[cyclohexane-1,5'-inden]-3-ene-2,6-dione
4-hydroxy-7-{[2-hydroxy-2-methyl-5-(prop-1-en-2-yl)cyclopentyl]methyl}-2-(2-hydroxypropan-2-yl)-3a-methyl-5-(2-methylbutanoyl)-2,3-dihydro-1-benzofuran-6-one
(1s,5r,8r,9r,11r,14s,17s,18s)-12-{4-[2-(dimethylamino)ethyl]phenoxymethyl}-5-methyl-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadeca-6,12-dien-9-ol
(1e)-2-[(1s,2s,7s)-2-[(2e)-4-methoxy-4-methylpent-2-en-1-yl]-5-(methoxymethyl)-2-methyl-6-oxo-7-(2-oxopropyl)cyclohept-4-en-1-yl]ethenyl 3-methylbut-2-enoate
(5r,7's,9's,13'r,16's,18's,19'r)-16',19'-dihydroxy-5,7',9',13',18'-pentamethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-10'-one
1-(5,6-dimethyl-3-oxoheptan-2-yl)-3a,7,8-trihydroxy-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
5,7',9',13'-tetramethyl-16'-oxo-5',17'-dioxaspiro[oxane-2,6'-pentacyclo[10.7.0.0²,⁹.0⁴,⁸.0¹⁴,¹⁸]nonadecan]-13'-ylacetic acid
(1s,2r,5r,6r,14r,16r)-n,n,6-trimethyl-5-[4-(3-methylpyridin-4-yl)butan-2-yl]-19-oxapentacyclo[14.2.1.0¹,⁹.0²,⁶.0¹¹,¹⁶]nonadeca-9,11-dien-14-amine
7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-2',8',14',16'-tetrol
(1e)-2-[(1s,3s,5s,11s,12r)-3-methoxy-11-[(2e)-4-methoxy-4-methylpent-2-en-1-yl]-3,11-dimethyl-2,6-dioxatricyclo[6.4.0.0¹,⁵]dodec-8-en-12-yl]ethenyl 3-methylbut-2-enoate
4-hydroxy-2-methyl-5-(nonadec-14-en-1-yl)-3,6-dioxocyclohexa-1,4-dien-1-yl acetate
(3s,4as,6s)-4a-(3,7-dimethylocta-2,6-dien-1-yl)-3,6-dihydroxy-2,2,6-trimethyl-8-[(2r)-2-methylbutanoyl]-3,4-dihydro-1-benzopyran-5,7-dione
(1r,3as,5as,7s,9ar,9br,11ar)-3a,7-dihydroxy-1-[(2r,3e,5r)-6-hydroxy-5-(hydroxymethyl)-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
1,3-dihydroxypropan-2-yl 3-(acetyloxy)-6-hydroxyicosanoate
(1r)-2-[(1r,2s,4as,4bs,8as,10as)-2-formyl-4b,8,8,10a-tetramethyl-decahydro-1h-phenanthren-1-yl]-1-(2-hydroxy-5-oxo-2h-furan-3-yl)ethyl acetate
(1'r,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,16'r,19'r)-16',19'-dihydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-10',15'-dione
(1s,3r,4ar,4bs,6as,10as,10bs,12as)-3-[(2r)-2-hydroxy-5-oxo-2h-furan-3-yl]-4b,7,7,10a-tetramethyl-tetradecahydrophenanthro[2,1-c]pyran-1-yl acetate
methyl 6'-(3-methoxy-3-oxopropyl)-2',3a,4,6',7-pentamethyl-6-oxo-5'-(prop-1-en-2-yl)-4,5-dihydro-3h-spiro[1-benzofuran-2,1'-cyclohexane]-5-carboxylate
(1r,3ar,5as,7s,9as,9bs,11ar)-7,9b-dihydroxy-1-[(2r,3e,5r)-6-hydroxy-5-(hydroxymethyl)-6-methylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-5-one
(1r,3as,3bs,7r,9s,9ar,9bs,10r,11as)-7,9,10-trihydroxy-9a-methyl-1-[(2r)-6-methyl-5-methylideneheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-11a-carboxylic acid
(1r,3'r,3'as,5r,7's,7'as)-2,3',7'-trihydroxy-3',5,7'-trimethyl-5-(3-methylbut-2-en-1-yl)-3-[(2s)-2-methylbutanoyl]-1',2',3'a,4',6',7'a-hexahydrospiro[cyclohexane-1,5'-inden]-2-ene-4,6-dione
(1s,2s,3r,4as,4br,6as,10as,10br,12s,12as)-2-acetyl-1-formyl-12-hydroxy-4b,7,7,10a,12a-pentamethyl-tetradecahydrochrysen-3-yl acetate
(1'r,2r,2'r,4's,7's,8's,9's,12's,13'r,14'r,16'r)-7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-2',8',14',16'-tetrol
7',16'-dihydroxy-4,5,5,7',9',13'-hexamethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-11'-one
(1'r,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,14's,18'r)-5,7',9',13'-tetramethyl-16'-oxo-5',17'-dioxaspiro[oxane-2,6'-pentacyclo[10.7.0.0²,⁹.0⁴,⁸.0¹⁴,¹⁸]nonadecan]-13'-ylacetic acid
(1r,3ar,3br,4r,9as,9bs,11as)-4-hydroxy-9a,11a-dimethyl-1-[(2s,3r,5s)-3,5,6-trihydroxy-5,6-dimethylheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
2-[8-(hydroxymethyl)-7,8-dimethoxy-2,5-dimethyl-5-(4-methylpent-3-en-1-yl)-4h,6h,7h-cyclohepta[b]furan-4-yl]ethenyl 3-methylbut-2-enoate
(1s,3s,5s,6s,8r,9s,10s,13r,14s,17s,19r,21r)-5,14-dimethyl-5-(4-methyl-3-methylidenepentyl)-2,4-dioxahexacyclo[11.8.0.0¹,⁹.0³,¹⁰.0⁶,¹⁰.0¹⁴,¹⁹]henicosane-8,17,21-triol
(1r)-2-[(1r,2s,4as,4bs,8as,10as)-2-formyl-4b,8,8,10a-tetramethyl-decahydro-1h-phenanthren-1-yl]-1-[(2r)-2-hydroxy-5-oxo-2h-furan-3-yl]ethyl acetate
4-hydroxy-9a,11a-dimethyl-1-(3,5,6-trihydroxy-5,6-dimethylheptan-2-yl)-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
n,n,6-trimethyl-5-[4-(3-methylpyridin-4-yl)butan-2-yl]-19-oxapentacyclo[14.2.1.0¹,⁹.0²,⁶.0¹¹,¹⁶]nonadeca-9,11-dien-14-amine
1',6,7',10,14-pentamethyl-3a,4,5,8,9,12,13,15a-octahydrospiro[cyclotetradeca[b]furan-3,10'-tricyclo[7.2.1.0²,⁸]dodecane]-2'(8'),3'-dien-2-one
(1r,3ar,3br,4r,9as,9bs,11as)-4-hydroxy-9a,11a-dimethyl-1-[(2s,3r,5r)-3,5,6-trihydroxy-5,6-dimethylheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
7,9,10-trihydroxy-9a-methyl-1-(6-methyl-5-methylideneheptan-2-yl)-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-11a-carboxylic acid
(3r)-17-oxo-3-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}octadecanoic acid
4-{4,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}pentanoic acid
1-(5,6-dimethylhept-3-en-2-yl)-3a,5a,7,9b-tetrahydroxy-9a,11a-dimethyl-1h,2h,3h,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-5-one
5,5a,8,10-tetrahydroxy-9a,11a-dimethyl-1-(6-methyl-5-methylideneheptan-2-yl)-1h,2h,3h,3ah,3bh,4h,5h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-9-one
(1r)-4-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-19-hydroxy-3,7,12,16-tetramethylnonadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-ol
3a,7,8-trihydroxy-9a,11a-dimethyl-1-{1-[3-(3-methylbutan-2-yl)oxiran-2-yl]ethyl}-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
1,3-dihydroxypropan-2-yl (3r,9r)-3-(acetyloxy)-9-hydroxyicosanoate
(1s,2s,5r,6s,9s,11r,13s,14s,15s,16r,18s,20r)-6,20-dimethyl-20-(4-methyl-3-methylidenepentyl)-17,19-dioxahexacyclo[14.4.1.0²,¹⁵.0²,¹⁸.0⁵,¹⁴.0⁶,¹¹]henicosane-9,13,14-triol
(3s,10r)-3-benzyl-12-hydroxy-10-(hydroxymethyl)-4,6-dimethyl-16-propyl-1-oxa-4,11-diazacyclohexadec-11-ene-2,5-dione
C26H40N2O5 (460.29370700000004)